Embecta Corp. EMBC
6.33 USD -0.19 (-2.91%)
At closeNov 5, 2026, 4:01 PM EST
6.33 0.00 0.00%
After hours · Nov 5, 4:01 PM ET
6.23 Day range 6.66
2.77 52-week range 14.91
- YTD
- -46.72%
- 1 year
- -54.33%
News
defenseworld.net Reviewing Rockwell Medical (NASDAQ:RMTI) & Embecta (NASDAQ:EMBC) Embecta (NASDAQ: EMBC - Get Free Report) and Rockwell Medical (NASDAQ: RMTI - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two…
globenewswire.com EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by…
globenewswire.com EMBECTA CORP. (NASDAQ: EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP , a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary duty by…
globenewswire.com embecta to Participate in Investor Events In September, embecta will participate in the Wells Fargo 2026 Healthcare Conference and the J.P. Morgan 4th Annual Nashville Healthcare Conference 2026.
newsfilecorp.com EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty New York, New York--(Newsfile Corp. - August 26, 2026) - Bernstein Liebhard LLP, a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary…
seekingalpha.com The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products Embecta offers a compelling deep value opportunity, trading at a P/E below 3x and free cash flow yield above 50%. Despite slightly declining sales and excessive debt, EMBC's high gross margins…
newsfilecorp.com EMBECTA CORP. (EMBC) SHAREHOLDER INVESTIGATION ALERT: Bernstein Liebhard Investigates Potential Breaches of Fiduciary Duty New York, New York--(Newsfile Corp. - August 18, 2026) - Bernstein Liebhard LLP, a nationally recognized investor rights law firm, announces that it is investigating potential breaches of fiduciary…
prnewswire.com EMBC Stock News: Embecta Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 57% Stock Drop A securities fraud class action lawsuit has been filed on behalf of Embecta investors after its stock plummeted over 57% because Embecta allegedly misled investors regarding the strength of its…
businesswire.com CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 NEW YORK--(BUSINESS WIRE)---- $EMBC #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Embecta Corp. (“Embecta” or the “Company”)…
gurufocus.com EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit PR Newswire NEW YORK
prnewswire.com EMBC Deadline: EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and May 4,…
globenewswire.com Bronstein, Gewirtz & Grossman LLC Urges Embecta Corp. Investors to Act: Class Action Filed Alleging Investor Harm NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Embecta…
businesswire.com EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $EMBC--EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law.
globenewswire.com EMBC Court News: Embecta Securities Fraud Class Action Filed After Insulin Pen Issues and 57% Stock Drop – Contact BFA Law Before August 17 NEW YORK, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Embecta Corp. (NASDAQ:EMBC) and certain…
prnewswire.com EMBC Investors Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit with SBS Law LOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Embecta Corp.…
prnewswire.com Embecta Corp. Sued for Securities Law Violations - FINAL DEADLINE TODAY - EMBC LOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Embecta Corp. ("Embecta" or "the Company") (NASDAQ: EMBC) for violations of §§10(b)…
globenewswire.com EMBC DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 17 Deadline in Securities Class Action – EMBC NEW YORK, Aug. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November 25, 2025 and…
newsfilecorp.com EMBC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Embecta To Contact Him Directly To Discuss Their Options If you purchased or…
newsfilecorp.com EMBC FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Embecta Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 17 Deadline in Securities Class Action - EMBC New York, New York--(Newsfile Corp. - August 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Embecta Corp. (NASDAQ: EMBC) between November…
gurufocus.com INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2026 INVESTOR DEADLINE APPROACHING: Faruqi and Faruqi, LLP Reminds Embecta (EMBC) Investors of Securities Class Action Lawsuit Deadline on August 17, 2
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers AVITA Medical (NASDAQ:RCEL) stock rose 58.4% to $7.53 during Friday's regular session. The company's market cap stands at $146.1 million. As per the press release, Q2 earnings came out…
benzinga.com Embecta Raises FY2026 Adj EPS Guidance from $1.55-$1.75 to $1.80-$1.90 vs $1.59 Est; Affirms FY2026 Sales Guidance of $1.015B-$1.035B vs $1.021B Est Embecta (NASDAQ:EMBC) raises FY2026 Adj EPS guidance from $1.55-$1.75 to $1.80-$1.90 vs $1.59 analyst estimate. Affirms FY2026 sales outlook from $1.015 billion-$1.035 billion to $1.015…
benzinga.com B of A Securities Maintains Underperform on Embecta, Lowers Price Target to $3 B of A Securities analyst Travis Steed maintains Embecta (NASDAQ:EMBC) with a Underperform and lowers the price target from $11 to $3.
benzinga.com Mizuho Maintains Neutral on Embecta, Lowers Price Target to $5 Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the price target from $12 to $5.
benzinga.com Crude Oil Down 4%; PayPal Shares Fall After Q1 Results US stocks rise, Nasdaq gains 1%. Dow up 0.57%, Nasdaq up 1.03%, S&P 500 up 0.84%. Materials up 2.1%, financials down 0.2%. PayPal shares fall 9%.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com Dow Jumps Over 300 Points; Pfizer Posts Upbeat Earnings US stocks rise, Dow gains 300 points. Materials jump 1.8%, real estate falls 0.2%. Pfizer's Q1 earnings beat expectations. Asian markets close lower.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com Embecta Lowers FY2026 Adj EPS Guidance from $2.80-$3.00 to $1.55-$1.75 vs $2.81 Est; Lowers FY2026 Sales Guidance from $1.071B-$1.093B to $1.015B-$1.035B vs $1.071B Est Embecta (NASDAQ:EMBC) lowers FY2026 Adj EPS guidance from $2.80-$3.00 to $1.55-$1.75 vs $2.81 analyst estimate. Lowers FY2026 sales outlook from $1.071 billion-$1.093 billion to $1.015 billion-$1.035…- benzinga.com Embecta Q2 Adj. EPS $0.27 Misses $0.42 Estimate, Sales $221.800M Miss $235.567M Estimate Embecta (NASDAQ:EMBC) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.42 by 35.71 percent. This is a 61.43 percent decrease over earnings of $0.70 per…
benzinga.com Under the Radar: Why "Fixing" a Great Strategy Usually Breaks It - benzinga.com Embecta Agrees To Acquire Owen Mumford For £150M Embecta Corp. ("Embecta") (NASDAQ:EMBC), a global leader in diabetes care technology, today announced that it has entered into a definitive agreement to acquire Owen Mumford Holdings Limited ("Owen…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Embecta Affirms FY2026 Adj EPS Guidance of $2.80-$3.00 vs $2.91 Est; Affirms FY2026 Sales Guidance of $1.071B-$1.093B vs $1.080B Est Embecta (NASDAQ:EMBC) affirms FY2026 Adj EPS guidance from $2.80-$3.00 to $2.80-$3.00 vs $2.91 analyst estimate. Affirms FY2026 sales outlook from $1.071 billion-$1.093 billion to $1.071…
benzinga.com Embecta Q1 Earnings Summary & Key Takeaways 
benzinga.com Embecta Q1 Adj. EPS $0.71 Beats $0.67 Estimate, Sales $261.200M Beat $258.043M Estimate Embecta (NASDAQ:EMBC) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.67 by 5.97 percent. This is a 9.23 percent increase over earnings of $0.65 per…- benzinga.com Earnings Scheduled For February 5, 2026
benzinga.com A Look Into Embecta Inc's Price Over Earnings 
benzinga.com Embecta Sees FY2026 Adj EPS $2.80-$3.00 vs $2.89 Est; Sees Sales $1.071B-$1.093B vs $1.082B Est Preliminary Fiscal Year 2026 Financial Guidance:For fiscal year 2026, the Company expects:Dollars in millions, except percentages and per share data Reported Revenues$1,071 - $1,093Reported Revenue…- benzinga.com Earnings Scheduled For November 25, 2025
benzinga.com Embecta's Earnings: A Preview - benzinga.com Embecta Devdatt Kurdikar To Become Chairman Of Board Embecta Corp. ("embecta") (NASDAQ:EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that David J.…
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Embecta Raises FY2025 Adj EPS Guidance from $2.70-$2.90 to $2.90-$2.95 vs $2.82 Est; Narrows FY2025 Sales Guidance from $1.073B-$1.090B to $1.078B-$1.085B vs $1.083B Est Fiscal Year 2025 Updated Financial Guidance:For fiscal year 2025, the Company now expects:Dollars in millions, except percentages and per share dataCurrentPrevious(1)Reported Revenues$1,078 -…
- benzinga.com Earnings Scheduled For August 8, 2025
benzinga.com An Overview of Embecta's Earnings - benzinga.com Mizuho Maintains Neutral on Embecta, Lowers Price Target to $12 Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the price target from $13 to $12.
- benzinga.com Mizuho Maintains Neutral on Embecta, Lowers Price Target to $13 Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:EMBC) with a Neutral and lowers the price target from $15 to $13.
benzinga.com Embecta Reaffirms 2025 Outlook With Up to $1.09B Revenue, Unveils Long-Term Plan to Cut $500M Debt Embecta Corp. ("embecta"; "The Company") (NASDAQ:EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its inaugural Analyst and Investor Day today to showcase…